Newborn Screening for Pompe Disease: Pennsylvania Experience.

International Journal of Neonatal Screening
Can FiciciogluRui Xiao

Abstract

Pennsylvania started newborn screening for Pompe disease in February 2016. Between February 2016 and December 2019, 531,139 newborns were screened. Alpha-Glucosidase (GAA) enzyme activity is measured by flow-injection tandem mass spectrometry (FIA/MS/MS) and full sequencing of the GAA gene is performed as a second-tier test in all newborns with low GAA enzyme activity [<2.10 micromole/L/h]. A total of 115 newborns had low GAA enzyme activity and abnormal genetic testing and were referred to metabolic centers. Two newborns were diagnosed with Infantile Onset Pompe Disease (IOPD), and 31 newborns were confirmed to have Late Onset Pompe Disease (LOPD). The incidence of IOPD + LOPD was 1:16,095. A total of 30 patients were compound heterozygous for one pathogenic and one variant of unknown significance (VUS) mutation or two VUS mutations and were defined as suspected LOPD. The incidence of IOPD + LOPD + suspected LOPD was 1: 8431 in PA. We also found 35 carriers, 15 pseudodeficiency carriers, and 2 false positive newborns.

References

Jan 26, 1999·JAMA : the Journal of the American Medical Association·P J MeikleW F Carey
Sep 10, 1999·Human Genetics·B J PoorthuisO P van Diggelen
Sep 14, 1999·European Journal of Human Genetics : EJHG·M G AusemsA T van der Ploeg
Mar 14, 2003·Biochimica Et Biophysica Acta·Reinout P HesselinkGer J Van der Vusse
Dec 20, 2003·European Journal of Human Genetics : EJHG·Rui PintoM C Sá Miranda
May 6, 2004·The Journal of Pediatrics·Priya Sunil Kishnani, R Rodney Howell
Oct 22, 2008·Lancet·Ans T van der Ploeg, Arnold J J Reuser
Jan 9, 2009·The New England Journal of Medicine·Nancy J MendelsohnPriya S Kishnani
Jun 13, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sarah P YoungDavid S Millington
Sep 25, 2009·Molecular Genetics and Metabolism·Priya S KishnaniY-T Chen
Jan 15, 2011·The Journal of Pediatrics·Yin-Hsiu ChienWuh-Liang Hwu
Jan 13, 2012·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Yoav H MessingerPriya S Kishnani
May 2, 2013·Pediatrics and Neonatology·Yin-Hsiu ChienNi-Chung Lee
Sep 3, 2013·American Journal of Medical Genetics. Part a·Priya S KishnaniUNKNOWN Pompe Registry Boards of Advisors
Dec 20, 2015·The Journal of Pediatrics·Chia-Feng YangDau-Ming Niu
Nov 23, 2017·Pediatrics·Olaf A BodamerUNKNOWN Pompe Disease Newborn Screening Working Group
Mar 30, 2018·Journal of Inherited Metabolic Disease·B PruniskiN Ali
Sep 15, 2018·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Zoheb B KaziPriya S Kishnani
Aug 9, 2019·Annals of Translational Medicine·Yin-Hsiu ChienNi-Chung Lee
May 1, 2020·International Journal of Neonatal Screening·Laurie D SmithArindam Bhattacharjee
Oct 20, 2020·International Journal of Neonatal Screening·Barbara K BurtonKhaja Basheeruddin
Oct 20, 2020·International Journal of Neonatal Screening·Tracy L KlugJami L Kiesling
Feb 10, 2021·International Journal of Neonatal Screening·Barbara K BurtonKhaja Basheeruddin
Feb 10, 2021·International Journal of Neonatal Screening·Tracy L KlugJami L Kiesling

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.